Our award-winning team creates custom content that inspires, engages, and informs the STAT News audience in medicine, health care, and the life sciences.
Joined April 2019
- Tweets74
- Following24
- Followers24
- Likes10
Cell and gene therapies are moving beyond cancer.
From CAR-T in autoimmune disease to pioneering in utero gene therapy, the field is entering a new era. Explore the science, regulation, clinical trials, and challenges shaping what's next.
Download the latest STAT e-book: shorturl.at/JqlJ7
Bringing a new therapy from discovery to patient care can take a decade or more, even when the science goes according to plan. At BIO 2026, industry leaders discussed why so many delays happen between stages of development and how AI, global collaboration, and stronger partnerships could help keep programs moving.
Read more: statnews.com/sponsor/2026/09…
Biotech has spent decades accelerating discovery. The next challenge? Making sure those breakthroughs reach patients.
At @STAT's Breakthrough West 2026, leaders from @Genentech discussed the gap between innovation and access — and how technology, data, and AI are helping bridge it.
Read more: statnews.com/sponsor/2026/08…
Many IBD patients eventually lose response to therapies that once worked. Johnson & Johnson's Esi Lamousé-Smith discusses how dual-pathway, co-antibody therapies could provide another treatment option while advancing more patient-centered care.
Read more: statnews.com/sponsor/2026/08…
Biology is evolving at a remarkable pace, and biomanufacturing must evolve with it. Daniel Bracewell, Professor at University College London, joined @STAT Brand Studio at the 2026 @Danaher Summit in London to discuss why staying current requires more than simply embracing AI — it also means keeping pace with the rapid evolution of biology itself.
Read more: tinyurl.com/3kmcc6sh
What is government's role in biomanufacturing innovation?
Steve Bates, OBE, Executive Chair of the U.K. Office for Life Sciences, joined @STAT Brand Studio moderator Jesse McQuarters at the 2026 @Danaher Summit in London to discuss why regulation is essential to bringing new bioprocessing technologies into health care. Bates explains why timely, appropriate oversight helps ensure innovation reaches patients safely and quickly.
Read more: fb.watch/IQOxqpUJNF/
You can't scale biologics without the people to make them.
At the 2026 Danaher Summit, Steve Bates, Dan Bracewell, and Alistair Stuart discussed why workforce development is becoming an essential piece of strategic infrastructure.
Four takeaways from the conversation, moderated by STAT Brand Studio and informed by new research from @Cytiva: statnews.com/sponsor/2026/08…
#Bioprocessing #Biopharma #Danaher #Cytiva
One study changed the conversation around HIV.
Fifteen years after HIV Prevention Trials Network (HPTN) 052, Jared Baeten of @Gilead reflects on how U=U transformed care, challenged stigma, and helped reshape the global HIV response, and why the work to end the epidemic is far from over.
Listen to the conversation here: shorturl.at/LsgOQ
AI is transforming health care, but much of the data structure powering today's models were built for a different era. Leslie Oley Wilberforce, CEO of @evidation, explains why the future of AI depends on building a richer, more continuous picture of patient health beyond the clinic.
Read more: statnews.com/sponsor/2026/07…
Driven by a deep heritage in science, @GileadSciences and @KitePharma are establishing their leadership in oncology.
Dietmar Berger, Chief Medical Officer of Gilead, shares his perspective on how advances in science, technology and collaboration are shaping their vision for the future of cancer care: statnews.com/sponsor/2026/07…
How are targeted therapies changing cancer care?
At ASCO 2026, @ChumiKhurana of Jazz Pharmaceuticals discusses precision oncology, advances in neuro-oncology, and the ongoing search for new options in rare cancers.
Read more: statnews.com/sponsor/2026/07…
Clinical research is entering a new era of speed and efficiency.
At Breakthrough West, @Medidata CEO Anthony Costello discussed how AI, wearable devices, and real-world data are accelerating research and bringing therapies to patients faster.
statnews.com/sponsor/2026/07…
How can AI help bring therapies to patients faster?
At STAT's Breakthrough West, @BioMarin's @arpitdave discussed how the company is using AI to support scientists, streamline workflows, and advance research for rare disease patients.
statnews.com/sponsor/2026/06…
How can innovation in oncology become more meaningful for patients? Dr. Mika Kakefuda Derynck of @GileadSciences and Dr. Gallia Levy of @KitePharma discuss advances in ADCs, CAR T-cell therapies and what it will take to bring these innovations to more people living with cancer.
statnews.com/sponsor/2026/06…
Cancer care is becoming increasingly personalized.
At STAT@ASCO, @GileadSciences CMO Dietmar Berger discussed how advances in cell therapy, antibody-drug conjugates, and other targeted approaches are helping researchers pursue new ways to treat cancer and improve outcomes for patients.
Aliza Apple of @EliLillyandCo and Aleksey Gerasyuto of Schrödinger joined the @statbrandstudio Multimedia Lounge at Breakthrough West to discuss how AI, physics-based modeling, and programmatic R&D are reshaping drug discovery. The conversation explored the cultural and scientific shifts required to move beyond traditional trial-and-error approaches and accelerate the path from discovery to development.
